Abstract
Structure-based ligand design is a technique that is used in the initial stages of a drug development programme. The role of various computational methods in the characterization of the chemical properties and behaviour of molecular systems is discussed. The determination of the three-dimensional properties of small molecules and macromolecular receptor structures is a core activity in the efforts towards a better understanding of structure-activity relationships.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fujita T. The extrathermodynamic approach to drug design. In: Hansch C, Sammes PG, Taylor JB, Ramdsen CA, editors. Comprehensive medicinal chemistry. vol. 4. Quantitative drug design. Oxford: Pergamon, 1990: 497–560.
Rekker R. The hydrophobic fragmental constant. Amsterdam: Elsevier Scientific Publishing, 1977.
Leo AJ. Calculating log Poct from structures. Chem Rev 1993;93:1281–1306.
Hansch C, Klein T, McClarin J, Langridge R, Cornell NW. A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase. J Med Chem 1986;29:615–20.
Tollenaere JP, Moereels H, Raymaekers LA. Structural aspects of the structure-activity relationships of neuroleptics: principles and methods. In: Ariëns EJ, editor. Drug design. Vol. 10. Oxford: Academic Press, 1980: 71–118.
Allen FH, Davies JE. File structures and search strategies for the Cambridge Structural Database. Crystallogr Comput 1988;2:271–89.
Bernstein FC, Koetzle TF, Williams GJB, Meyer EF, Brice MD, Rodgers JR, et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol 1977;112:535–42.
Wüthrich K. The development of nuclear magnetic resonance spectroscopy as a technique for protein structure determination. Acc Chem Res 1989;22:36–44.
Lee GM, Chen C, Marchner TM, Andersen NH. Does the solid-state structure of endothelin-1 provide insights concerning the solution-state conformational equilibrium? FEBS Lett 1994;355:140–6.
Leach AR. A survey of methods for searching the conformational space of small and medium-sized molecules. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 2. Weinheim: VCH Publishers, 1991:1–55.
Howard AE, Kollman PA. An analysis of the current methodologies for conformational searching of complex molecules. J Med Chem 1988;31:1669–75.
Wilson SR, Cui W, Moskowitz JM, Schmidt KE. Applications of simulated annealing to the conformational analysis of flexible molecules. J Comput Chem 1991;12:342–9.
Nayeem A, Villa J, Scheraga HA. A comparative study of simulated-annealing and Monte Carlo with minimization approaches to the minimum-energy structures of polypeptides: [Met]-enkephalin. J Comput Chem 1991;12:594–605.
Zerner MC. Semiempirical molecular orbital methods. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 2. Weinheim: VCH Publishers, 1991:313–65.
Siebel GL, Kollman PA. Molecular mechanics and the modelling of drug structures. In: Hansch C, Sammes PG, Taylor JB, Ramdsen CA, editors. Comprehensive medicinal chemistry. Vol. 4. Quantitative drug design. Oxford: Pergamon, 1990: 125–38.
Bowen JP, Allinger NL. Molecular mechanics: The art and science of parametrization. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 2. Weinheim: VCH Publishers, 1991:81–97.
Brooks BR, Bruccoleri ER, Olafson ER, States DJ, Swaminathan S, Karplus M. CHARMm: A program for macromolecular energy minimization and dynamic calculations. J Comput Chem 1983;4:187–217.
Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, et al. A new fore field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106:765–84.
Clark M, Cramer RD III, Van Opdenbosch N. Validation of the general purpose tripos 5.2 force field. J Comput Chem 1989;10:982–1012.
Dinur U, Hagler AT. New approaches to empirical force fields. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 2. Weinheim: VCH Publishers, 1991:99–164.
van Gunsteren WF, Berendsen HJC. Computer simulation of molecular dynamics: methodology, applications and perspectives in chemistry. Angew Chem 1990;29:992–1023.
Brunger AT, Karplus M. Molecular dynamics simulations with experimental restraints. Acc Chem Res 1991;24:54–61.
Sheridan RP, Rushinko A III, Nilakantan R, Venkataraghavan R. Searching for pharmacophores in large coordinate data bases and its use in drug design. Proc Natl Acad Sci USA 1989;86:8165–9.
Martin YC, Bures MG, Willet P. Searching databases of three-dimensional structures. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 2. Weinheim. VCH Publishers, 1991:213–63.
Zuckermann RN, Kerr JM, Kent SBH, Moos WH. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J Am Chem Soc 1992;114:10646–7.
Simon RJ, Kania RS, Zuckermann RN,Huebner VD, Jewell DA, Banville S, et al. Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci USA 1992;89:9367–71.
Zuckermann RN, Martin EJ, Spellmeyer DC, Stauber GB, Shoemaker KR, Kerr JM, et al. Discovery of nanomolar ligands for 7-transmembrane G-protein coupled receptors from a diverse (N-substituted) glycine peptoid library. J Med Chem 1994;37:2678–85.
Felder ER. The challenge of preparing and testing combinatorial compound libraries in the fast lane, at the front end of drug development. Chimia 1994;48:531–41.
Liskamp RMJ. Opportunities for new libraries: unnatural biopolymer and diversomers. Angew Chem Int Ed (Engl) 1994; 33:633–6.
Chen JK, Schreiber SL. Kombinatorische Synthese und mehr-dimensionale NMR-Spektroskopie: ein Beitrag zum Verstandnis von Protein-Ligand-Wechselwirkungen. Angew Chem 1995;107:1041–58.
Chothia C, Lesk AM. The relation between the divergence of sequence and structure in proteins. EMBO J 1986;5:823–6.
Böhm H-J. The computer program LUDI: a new methods for thede novo design of enzyme inhibitors. J Comput-Aided Mol Design 1992;6:61–78.
Böhm H-J. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput-Aided Mol Design 1994;8:243–56.
Leach AR, Kilvington SR. Automated molecular design: a new fragment-joining algorithm. J Comput-Aided Mol Design 1994;8:283–98.
Kollman P. Free energy calculations: applications to chemical and biochemical phenomena. Chem Rev 1993;93:2395–2417.
Loew GH, Villar HO, Alkorta I. Strategies for indirect computer-aided drug design. Pharm Res 1993;10:475–86.
Lam PYS, Jadhav PK, Eyermann CJ, Hodge CN, Ru Y, Bacheler LT, et al. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 1994;263:380–4.
Colman PM. Structure-based drug design. Curr Opin Struct Biol 1994;4:868–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tollenaere, J.P. The role of structure-based ligand design and molecular modelling in drug discovery. Pharm World Sci 18, 56–62 (1996). https://doi.org/10.1007/BF00579706
Issue Date:
DOI: https://doi.org/10.1007/BF00579706